Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -3.12k | 40.62k | 売り | 13.04 | 256.73k | -1.20% |
| 2026-04-27 | Ms. Julie RubinsteinPresident & COO | -4.33k | 61.62k | Automatic Disposition | 14.23 | 377.80k | -1.13% |
| 2026-04-27 | Ms. Julie RubinsteinPresident & COO | -14.71k | 84.86k | Derivative Exercise and Sale | 8.46 - 14.23 | 377.80k | - |
| 2026-04-22 | Ms. Julie RubinsteinPresident & COO | -44.17k | 243.06k | Derivative Exercise and Sale | 8.46 - 14.13 | 382.13k | - |
| 2026-04-22 | Ms. Julie RubinsteinPresident & COO | -13.01k | 181.72k | Automatic Disposition | 13.74 - 14.13 | 382.13k | -3.29% |
| 2026-04-17 | Ms. Julie RubinsteinPresident & COO | -56.05k | 300.82k | Derivative Exercise and Sale | 8.46 - 14.66 | 395.15k | - |
| 2026-04-17 | Ms. Julie RubinsteinPresident & COO | -13.01k | 189.92k | Automatic Disposition | 14.55 - 14.66 | 395.15k | -3.19% |
| 2026-04-14 | Ms. Julie RubinsteinPresident & COO | -44.17k | 264.55k | Derivative Exercise and Sale | 8.46 - 14.61 | 408.16k | - |
| 2026-04-14 | Ms. Julie RubinsteinPresident & COO | -13.01k | 188.05k | Automatic Disposition | 14.18 - 14.61 | 408.16k | -3.09% |
| 2026-04-09 | Ms. Julie RubinsteinPresident & COO | -44.17k | 252.42k | Derivative Exercise and Sale | 7.27 - 13.79 | 421.17k | - |
| 2026-04-09 | Ms. Julie RubinsteinPresident & COO | -13.01k | 176.74k | Automatic Disposition | 12.75 - 14.44 | 421.17k | -3.00% |
| 2026-04-08 | Mr. Francis T. LoCPO | -2.34k | 25.97k | Derivative Exercise and Sale | 3.99 - 15.07 | 273.65k | - |
| 2026-04-08 | Mr. Francis T. LoCPO | -20.22k | 304.72k | Automatic Disposition | 15.07 | 273.65k | -6.88% |
| 2026-04-08 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -10.00k | 148.50k | Automatic Disposition | 14.85 | 1.51M | -0.66% |
| 2026-04-06 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -120.60k | 1.77M | Automatic Disposition | 14.41 - 15.19 | 1.52M | -7.35% |
| 2026-04-06 | Ms. Julie RubinsteinPresident & COO | -56.05k | 339.80k | Derivative Exercise and Sale | 7.27 - 14.83 | 434.19k | - |
| 2026-04-06 | Ms. Julie RubinsteinPresident & COO | -13.01k | 185.38k | Automatic Disposition | 13.56 - 15.48 | 434.19k | -2.91% |
| 2026-04-01 | Ms. Julie RubinsteinPresident & COO | -29.44k | 213.62k | Derivative Exercise and Sale | 7.27 - 14.60 | 447.20k | - |
| 2026-04-01 | Ms. Julie RubinsteinPresident & COO | -8.68k | 126.02k | Automatic Disposition | 14.45 - 14.60 | 447.20k | -1.90% |
| 2026-03-27 | Ms. Julie RubinsteinPresident & COO | -44.17k | 258.60k | Derivative Exercise and Sale | 7.27 - 13.48 | 455.88k | - |
| 2026-03-27 | Ms. Julie RubinsteinPresident & COO | -13.01k | 171.61k | Automatic Disposition | 12.63 - 13.48 | 455.88k | -2.78% |
| 2026-03-24 | Ms. Julie RubinsteinPresident & COO | -13.01k | 182.59k | Automatic Disposition | 13.70 - 14.27 | 468.89k | -2.70% |
| 2026-03-24 | Ms. Julie RubinsteinPresident & COO | -44.17k | 298.56k | Derivative Exercise and Sale | 7.27 - 14.27 | 468.89k | - |
| 2026-03-19 | Ms. Julie RubinsteinPresident & COO | -13.01k | 175.17k | Automatic Disposition | 13.18 - 13.83 | 481.91k | -2.63% |
| 2026-03-19 | Ms. Julie RubinsteinPresident & COO | -44.17k | 286.82k | Derivative Exercise and Sale | 6.55 - 13.83 | 481.91k | - |
| 2026-03-16 | Ms. Julie RubinsteinPresident & COO | -44.17k | 299.45k | Derivative Exercise and Sale | 6.55 - 13.41 | 494.92k | - |
| 2026-03-16 | Ms. Julie RubinsteinPresident & COO | -13.01k | 173.48k | Automatic Disposition | 13.18 - 13.41 | 494.92k | -2.56% |
| 2026-03-11 | Ms. Julie RubinsteinPresident & COO | -44.17k | 295.58k | Derivative Exercise and Sale | 6.55 - 14.08 | 507.93k | - |
| 2026-03-11 | Ms. Julie RubinsteinPresident & COO | -122.52k | 1.61M | 売り | 13.17 | 507.93k | -19.43% |
| 2026-03-11 | Ms. Julie RubinsteinPresident & COO | -13.01k | 175.56k | Automatic Disposition | 12.96 - 14.08 | 507.93k | -2.50% |
| 2026-03-11 | Ms. Michelle GriffinIndependent Director | -15.39k | 214.13k | 売り | 13.91 | 15.63k | -49.63% |
| 2026-03-11 | Mr. Francis T. LoCPO | -30.59k | 430.75k | Automatic Disposition | 14.08 | 293.87k | -9.43% |
| 2026-03-11 | Ms. Susan BobulskyChief Commercial Officer of MRD | -41.34k | 544.42k | 売り | 13.17 | 427.78k | -8.81% |
| 2026-03-11 | Dr. Sharon BenzenoChief Commercial Officer of Immune Medicine | -63.10k | 831.07k | 売り | 13.17 | 272.75k | -18.79% |
| 2026-03-11 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -18.67k | 245.91k | 売り | 13.17 | 259.84k | -6.70% |
| 2026-03-11 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -470.27k | 6.19M | 売り | 13.17 | 1.52M | -23.60% |
| 2026-03-11 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -470.17k | 6.19M | 売り | 13.17 | 1.64M | -22.27% |
| 2026-03-06 | Ms. Julie RubinsteinPresident & COO | -68.33k | 435.60k | Derivative Exercise and Sale | 6.55 - 15.14 | 643.47k | - |
| 2026-03-06 | Ms. Julie RubinsteinPresident & COO | -13.01k | 193.52k | Automatic Disposition | 14.68 - 15.14 | 643.47k | -1.98% |
| 2026-03-05 | Mr. Francis T. LoCPO | -38.07k | 574.54k | 売り | 15.09 | 324.47k | -10.50% |
| 2026-03-03 | Ms. Michelle GriffinIndependent Director | -48.04k | 543.38k | Derivative Exercise and Sale | 3.99 - 15.30 | 15.39k | - |
| 2026-03-03 | Ms. Julie RubinsteinPresident & COO | -79.81k | 559.18k | Derivative Exercise and Sale | 6.55 - 16.60 | 575.24k | - |
| 2026-03-03 | Ms. Julie RubinsteinPresident & COO | -13.01k | 212.26k | Automatic Disposition | 16.00 - 16.60 | 575.24k | -2.21% |
| 2026-03-02 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -24.23k | 392.33k | Automatic Disposition | 15.72 - 16.52 | 1.16M | -2.05% |
| 2026-02-27 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -525.00k | 8.32M | Automatic Disposition | 15.49 - 16.15 | 1.07M | -32.83% |
| 2026-02-04 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -2.15k | 13.56k | Derivative Exercise and Sale | 12.14 - 18.46 | 3.22k | - |
| 2026-02-02 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -42.79k | 799.10k | Automatic Disposition | 18.60 - 19.00 | 1.18M | -3.50% |
| 2026-02-02 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -125.00k | 2.30M | Automatic Disposition | 18.44 | 1.60M | -7.25% |
| 2026-01-12 | Mr. Francis T. LoCPO | -79.59k | 797.11k | Derivative Exercise and Sale | 3.99 - 17.73 | 318.48k | - |
| 2026-01-12 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -4.29k | 25.14k | Derivative Exercise and Sale | 12.14 - 18.00 | 3.22k | - |
| 2026-01-06 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -10.00k | 164.40k | Automatic Disposition | 16.44 | 1.22M | -0.81% |
| 2025-12-22 | Mr. Francis T. LoCPO | -4.39k | 50.25k | Derivative Exercise and Sale | 3.99 - 17.50 | 318.48k | - |
| 2026-01-05 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -125.00k | 1.95M | Automatic Disposition | 15.59 | 1.72M | -6.76% |
| 2026-01-02 | Mr. Francis T. LoCPO | -3.13k | 37.78k | Derivative Exercise and Sale | 3.99 - 16.08 | 318.48k | - |
| 2025-12-15 | Mr. Francis T. LoCPO | -97.02k | 892.87k | Derivative Exercise and Sale | 3.99 - 15.57 | 318.48k | - |
| 2025-12-15 | Mr. Francis T. LoCPO | -16.87k | 262.63k | Automatic Disposition | 15.57 | 318.48k | -5.03% |
| 2025-12-10 | Dr. Robert M. HershbergIndependent Director | -22.97k | 367.49k | 売り | 16.00 | 46.72k | -32.96% |
| 2025-12-04 | Dr. Sharon BenzenoChief Commercial Officer of Immune Medicine | -12.60k | 108.54k | Derivative Exercise and Sale | 3.99 - 16.85 | 296.79k | - |
| 2025-12-03 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -37.21k | 672.52k | Automatic Disposition | 16.61 - 18.61 | 1.23M | -2.93% |
| 2025-11-28 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -110.11k | 893.68k | Derivative Exercise and Sale | 6.55 - 19.50 | 3.22k | - |
| 2025-11-28 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -52.71k | 1.03M | Automatic Disposition | 19.50 | 3.22k | -94.24% |
| 2025-11-26 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -160.73k | 3.07M | Automatic Disposition | 18.94 - 19.68 | 1.85M | -8.00% |
| 2025-11-20 | Dr. Sharon BenzenoChief Commercial Officer of Immune Medicine | -510.47k | 4.09M | Derivative Exercise and Sale | 3.99 - 16.91 | 296.79k | - |
| 2025-11-20 | Dr. Sharon BenzenoChief Commercial Officer of Immune Medicine | -95.93k | 1.59M | Automatic Disposition | 16.54 | 296.79k | -24.43% |
| 2025-11-17 | Mr. Kyle PiskelVP, CFO & Principal Accounting Officer | -238.00 | 3.34k | 売り | 14.05 | 55.93k | -0.42% |
| 2025-11-10 | Dr. Harlan S. RobinsCo-Founder & Chief Scientific Officer | -10.00k | 148.20k | Automatic Disposition | 14.82 | 1.27M | -0.78% |
| 2025-11-10 | Mr. Chad M. RobinsCo-Founder, CEO & Chairman | -89.27k | 1.32M | Automatic Disposition | 14.57 - 15.00 | 2.01M | -4.25% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
